FDA Grants 510(k) Clearance for AI Detection and Triage of Cervical Spine Fractures
The CINA-CSpine AI software reportedly demonstrated a 90.3 percent sensitivity rate for cervical spine fractures in validation testing on more than 300 non-contrast CT scans.
The CINA-CSpine artificial intelligence (AI) software has garnered 510(k) clearance from the Food and Drug Administration (FDA) for the detection and triage of cervical spine fractures on computed tomography (CT) scans.
Facilitating timely treatment of cervical spine fractures, the CINA-CSpine software provides automated flagging of suspected acute fractures and subsequent alerts to reviewing radiologists, according to Avicenna.AI, the developer of the software.
In validation testing involving over 300 CT scans acquired from 36 scanner models and five different vendors, the company said the newly FDA-cleared CINA-CSpine software demonstrated a 90.3 percent sensitivity for cervical spine fractures. (Photo courtesy of Avicenna.AI .)
In validation testing involving over 300 CT scans acquired from 36 scanner models and five different vendors, the company said the CINA-CSpine software demonstrated a 90.3 percent sensitivity rate and a 91.9 percent specificity rate for cervical spine fractures.
"These results demonstrate that our CINA-CSpine algorithm is capable of providing prompt and accurate findings that could positively guide physicians towards better assessments and improved patient outcomes," added Cyril Di Grandi, the co-founder and chief executive officer of Avicenna.ai.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
New bpMRI Study Suggests AI Offers Comparable Results to Radiologists for PCa Detection
April 15th 2025Demonstrating no significant difference with radiologist detection of clinically significant prostate cancer (csPCa), a biparametric MRI-based AI model provided an 88.4 percent sensitivity rate in a recent study.
